Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Delayed Quote USD

Solesence, Inc. Common Stock (SLSN)

3.0900
-0.0400
(-1.28%)
At close: 4:00:00 PM EDT
3.0399
-0.05
(-1.62%)
After hours: 5:28:28 PM EDT
Loading Chart for SLSN
  • Previous Close 3.1300
  • Open 3.1500
  • Bid 3.0100 x 200
  • Ask 3.1500 x 100
  • Day's Range 3.0100 - 3.2400
  • 52 Week Range 1.2100 - 16.5600
  • Volume 73,529
  • Avg. Volume 118,390
  • Market Cap (intraday) 216.619M
  • Beta (5Y Monthly) 0.77
  • PE Ratio (TTM) 44.14
  • EPS (TTM) 0.0700
  • Earnings Date May 5, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Solesence, Inc., a science-driven company, develops, manufactures, and sells integrated family of technologies in the United States. The company engages in engineered materials, formulation development, and commercial manufacturing. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients under the Solésence brand; skin health products, such as sunscreens and daily care products; and advanced material products, including architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, and medical diagnostics applications. The company was formerly known as Nanophase Technologies Corporation and changed its name to Solesence, Inc. in March 2025. Solesence, Inc. was incorporated in 1989 and is headquartered in Romeoville, Illinois.

solesence.com

98

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SLSN

View More

Performance Overview: SLSN

Trailing total returns as of 5/5/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SLSN
26.64%
S&P 500 (^GSPC)
3.93%

1-Year Return

SLSN
117.61%
S&P 500 (^GSPC)
10.19%

3-Year Return

SLSN
8.80%
S&P 500 (^GSPC)
36.26%

5-Year Return

SLSN
530.61%
S&P 500 (^GSPC)
96.98%

Compare To: SLSN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SLSN

View More

Valuation Measures

Annual
As of 5/2/2025
  • Market Cap

    219.42M

  • Enterprise Value

    233.31M

  • Trailing P/E

    44.71

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.89

  • Price/Book (mrq)

    14.68

  • Enterprise Value/Revenue

    4.46

  • Enterprise Value/EBITDA

    38.50

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.09%

  • Return on Assets (ttm)

    7.74%

  • Return on Equity (ttm)

    50.27%

  • Revenue (ttm)

    52.35M

  • Net Income Avi to Common (ttm)

    4.24M

  • Diluted EPS (ttm)

    0.0700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.41M

  • Total Debt/Equity (mrq)

    102.35%

  • Levered Free Cash Flow (ttm)

    -3.44M

Research Analysis: SLSN

View More

Company Insights: SLSN

Research Reports: SLSN

View More

People Also Watch